바이오모아 (BioMoa) — ADC · Antibody

8428프로그램 40FDA 승인

0오늘 방문

1,453누적 방문

7303갱신 대기 S–CData Tier S/A/B차세대 1032HER2 breast 4683Antibody 2713CGT →Psoriasis →NSCLC 40FDA 승인

피드 Data Tier 차세대

최근 활동

RSS →

CGTBiologicstaleJuventas Cell Therapy Ltd.Phase 1

CNCT19 CAR-T cell therapy (CNCT19 CAR-T cell therapy)

Autoimmune Hemolytic Anemia; Autologous CD19 CAR-T · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 1상태 RECRUITING

AntibodystaleTaizhou Mabtech Pharmaceutical …Phase 3

CMAB007 (CMAB007)

Chronic Spontaneous Urticaria · Chronic Spontaneous Urticaria

#ChronicSpontaneousUrticaria#Antibody#Phase3#항체#면역항체+2

임상시험 1상태 RECRUITING

CGTBiologicstaleYake Biotechnology Ltd.Phase 1

CD19/BCMA Targeted CAR T-cells and dasatinib (CD19/BCMA Targeted CAR T-cells and dasatinib)

Multiple Myeloma in Relapse; Multiple Myeloma, Refractory · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+5

임상시험 1상태 RECRUITING

AntibodystaleLei LiuPhase 2

MRG003 combined with Pucotenlimab+Cisplatin (MRG003 combined with Pucotenlimab+Cisplatin)

Head and Neck Squamous Cell Carcinoma (HNSCC) · Head and Neck Squamous Cell Carcinoma (H

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase2#항체#면역항체+2

임상시험 1상태 RECRUITING

CGTBiologicstaleWashington Research FoundationPhase 1

FH FOLR1 ST CAR T-cells (FH FOLR1 ST CAR T-cells)

Advanced Osteosarcoma; Recurrent Osteosarcoma · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 1상태 RECRUITING

AntibodystaleAmgenPhase 3

AMG 162 (Denosumab, Denosumab (AMG 162))

Postmenopausal Osteoporosis · Postmenopausal Osteoporosis

#PostmenopausalOsteoporosis#Antibody#Phase3#항체#면역항체+2

효능 ORR 5%임상시험 1상태 ACTIVE

CGTBiologicstaleBlueWhale Bio (Cohort D only)Phase 1

huCART19-IL18 (huCART19-IL18)

Chronic Lymphocytic Leukemia; Non-hodgkin Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 RECRUITING

AntibodystaleThe First Affiliated Hospital o…Phase 2

Adebrelimab Combined with Bevacizumab and Docetaxel (Adebrelimab Combined with Bevacizumab and Docetaxel)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#항체#면역항체+2

임상시험 1상태 ACTIVE

AntibodystaleWeill Medical College of Cornel…Phase 2

mesna, cisplatin, etoposide, rituximab (mesna, cisplatin, etoposide, rituximab)

Non-Hodgkin's Lymphoma · Non-Hodgkin's Lymphoma

#Non-HodgkinsLymphoma#Antibody#Phase2#항체#면역항체+2

효능 ORR 83%임상시험 1상태 ACTIVE

AntibodystaleSeagen Inc.Phase 1

lintuzumab (lintuzumab)

Myelodysplastic Syndrome (MDS) · Myelodysplastic Syndrome (MDS)

#MyelodysplasticSyndromeMDS#Antibody#Phase1#항체#면역항체+2

효능 ORR 14%임상시험 1상태 ACTIVE

AntibodystaleBioXcel Therapeutics IncPhase 2

pembrolizumab (Keytruda, BXCL701 plus Pembrolizumab)

Prostate Cancer; Neuroendocrine Tumors · Prostate Cancer

#ProstateCancer#Antibody#Phase2#항체#면역항체+3

임상시험 1상태 ACTIVE

ADCBiologicstaleImmunoGen, Inc.Phase 1

HuC242-DM4 (HuC242-DM4)

Non-colorectal Cancer; Pancreatic Cancer · Non-colorectal Cancer

#Non-colorectalCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 ACTIVE

CGTBiologicBio4T2 LLCPhase 1

B4T2-001 Autologous CAR T cells (B4T2-001 Autologous CAR T cells)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#CGT#Phase1#세포유전치료#CAR-T+2

임상시험 1상태 RECRUITING

CGTBiologicstaleGuangdong Zhaotai Cell Bio-tech…Phase 2

CAT19T2 (CD19 CAR T-Cell, CD19 CAR T-Cell(CAT19T2))

B-cell Acute Lymphoblastic Leukemia; B-Cell Lymphoma, Unspecified · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+5

임상시험 1상태 DISCONTINUED

AntibodystaleAIO-Studien-gGmbHPhase 2

trastuzumab (Herceptin, Post-operative treatment trastuzumab mono therapy)

Adenocarcinoma of the Gastroesophageal Junction; Adenocarcinoma of the Stomach · Adenocarcinoma of the Gastroesophageal J

#AdenocarcinomaoftheGastroesophag#Antibody#Phase2#항체#면역항체+3

임상시험 1상태 ACTIVE

AntibodystaleShandong Cancer Hospital and In…Phase 2

trastuzumab (Herceptin, Capecitabine,Trastuzumab, and Pertuzumab)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+2

효능 ORR 30%임상시험 1상태 ACTIVE

AntibodystaleDizal PharmaceuticalsPhase 2

DZD9008 plus Bevacizumab (DZD9008 plus Bevacizumab)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#항체#면역항체+2

임상시험 1상태 RECRUITING

CGTBiologicstaleGuangzhou Anjie Biomedical Tech…Phase 2

CAR-T combining PD-1 Knockout (CAR-T combining PD-1 Knockout)

Lung Neoplasm Malignant; Non-small Cell Lung Cancer · PD-1

#PD-1#CGT#Phase2#세포유전치료#CAR-T+4

임상시험 1상태 ACTIVE

AntibodystaleBristol Myers SquibbPhase 2

Ipilimumab Injection [Yervoy] (Ipilimumab Injection [Yervoy])

Malignant Melanoma · Malignant Melanoma

#MalignantMelanoma#Antibody#Phase2#항체#면역항체+2

임상시험 1상태 RECRUITING

AntibodystaleUniversity of OxfordPhase 2

Sotrovimab (Sotrovimab)

COVID-19 · COVID-19

#COVID-19#Antibody#Phase2#항체#면역항체+2

임상시험 1상태 RECRUITING

AntibodystaleAstraZenecaPhase 3

Brazikumab high dose (Brazikumab high dose)

Crohn's Disease; IBD · Crohn's Disease

#CrohnsDisease#Antibody#Phase3#항체#면역항체+3

임상시험 1상태 DISCONTINUED

ADCBiologicstalePeking University Third HospitalPhase 2

Chemotherapy (Gemcitabine, Gemcitabine (Chemotherapy))

Muscle-Invasive Bladder Cancer (MIBC) · Muscle-Invasive Bladder Cancer (MIBC)

#Muscle-InvasiveBladderCancerMIBC#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

AntibodystaleHenan Cancer HospitalPreclinical

trastuzumab (Herceptin, Pyrotinib and Trastuzumab plus Vinorelbine)

HER2 Positive Breast Cancer · HER2

#HER2#Antibody#Preclinical#항체#면역항체+3

임상시험 1상태 ACTIVE

AntibodystaleUniversity Hospital, Strasbourg…Approved

abatacept, rituximab or tocilizumab (abatacept, rituximab or tocilizumab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2

임상시험 1상태 ACTIVE

CGTBiologicstaleWellington Zhaotai Therapies Li…Phase 1

1928T2z CAR-T cells (WZTL002-1, WZTL002-1 (1928T2z CAR-T cells))

Lymphomas Non-Hodgkin's B-Cell; Diffuse Large B-cell Lymphoma (DLBCL) · Lymphomas Non-Hodgkin's B-Cell

#LymphomasNon-HodgkinsB-Cell#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 RECRUITING

118 / 142 페이지

← 이전 다음 →

전체 8,428개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 0 / 1,453

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

CNCT19 CAR-T cell therapy (CNCT19 CAR-T cell therapy)

CMAB007 (CMAB007)

CD19/BCMA Targeted CAR T-cells and dasatinib (CD19/BCMA Targeted CAR T-cells and dasatinib)

MRG003 combined with Pucotenlimab+Cisplatin (MRG003 combined with Pucotenlimab+Cisplatin)

FH FOLR1 ST CAR T-cells (FH FOLR1 ST CAR T-cells)

AMG 162 (Denosumab, Denosumab (AMG 162))

huCART19-IL18 (huCART19-IL18)

Adebrelimab Combined with Bevacizumab and Docetaxel (Adebrelimab Combined with Bevacizumab and Docetaxel)

mesna, cisplatin, etoposide, rituximab (mesna, cisplatin, etoposide, rituximab)

lintuzumab (lintuzumab)

pembrolizumab (Keytruda, BXCL701 plus Pembrolizumab)

HuC242-DM4 (HuC242-DM4)

B4T2-001 Autologous CAR T cells (B4T2-001 Autologous CAR T cells)

CAT19T2 (CD19 CAR T-Cell, CD19 CAR T-Cell(CAT19T2))

trastuzumab (Herceptin, Post-operative treatment trastuzumab mono therapy)

trastuzumab (Herceptin, Capecitabine,Trastuzumab, and Pertuzumab)

DZD9008 plus Bevacizumab (DZD9008 plus Bevacizumab)

CAR-T combining PD-1 Knockout (CAR-T combining PD-1 Knockout)

Ipilimumab Injection [Yervoy] (Ipilimumab Injection [Yervoy])

Sotrovimab (Sotrovimab)

Brazikumab high dose (Brazikumab high dose)

Chemotherapy (Gemcitabine, Gemcitabine (Chemotherapy))

trastuzumab (Herceptin, Pyrotinib and Trastuzumab plus Vinorelbine)

abatacept, rituximab or tocilizumab (abatacept, rituximab or tocilizumab)

1928T2z CAR-T cells (WZTL002-1, WZTL002-1 (1928T2z CAR-T cells))

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

CNCT19 CAR-T cell therapy (CNCT19 CAR-T cell therapy)

CMAB007 (CMAB007)

CD19/BCMA Targeted CAR T-cells and dasatinib (CD19/BCMA Targeted CAR T-cells and dasatinib)

MRG003 combined with Pucotenlimab+Cisplatin (MRG003 combined with Pucotenlimab+Cisplatin)

FH FOLR1 ST CAR T-cells (FH FOLR1 ST CAR T-cells)

AMG 162 (Denosumab, Denosumab (AMG 162))

huCART19-IL18 (huCART19-IL18)

Adebrelimab Combined with Bevacizumab and Docetaxel (Adebrelimab Combined with Bevacizumab and Docetaxel)

mesna, cisplatin, etoposide, rituximab (mesna, cisplatin, etoposide, rituximab)

lintuzumab (lintuzumab)

pembrolizumab (Keytruda, BXCL701 plus Pembrolizumab)

HuC242-DM4 (HuC242-DM4)

B4T2-001 Autologous CAR T cells (B4T2-001 Autologous CAR T cells)

CAT19T2 (CD19 CAR T-Cell, CD19 CAR T-Cell(CAT19T2))

trastuzumab (Herceptin, Post-operative treatment trastuzumab mono therapy)

trastuzumab (Herceptin, Capecitabine,Trastuzumab, and Pertuzumab)

DZD9008 plus Bevacizumab (DZD9008 plus Bevacizumab)

CAR-T combining PD-1 Knockout (CAR-T combining PD-1 Knockout)

Ipilimumab Injection [Yervoy] (Ipilimumab Injection [Yervoy])

Sotrovimab (Sotrovimab)

Brazikumab high dose (Brazikumab high dose)

Chemotherapy (Gemcitabine, Gemcitabine (Chemotherapy))

trastuzumab (Herceptin, Pyrotinib and Trastuzumab plus Vinorelbine)

abatacept, rituximab or tocilizumab (abatacept, rituximab or tocilizumab)

1928T2z CAR-T cells (WZTL002-1, WZTL002-1 (1928T2z CAR-T cells))

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

CNCT19 CAR-T cell therapy (CNCT19 CAR-T cell therapy)

CMAB007 (CMAB007)

CD19/BCMA Targeted CAR T-cells and dasatinib (CD19/BCMA Targeted CAR T-cells and dasatinib)

MRG003 combined with Pucotenlimab+Cisplatin (MRG003 combined with Pucotenlimab+Cisplatin)

FH FOLR1 ST CAR T-cells (FH FOLR1 ST CAR T-cells)

AMG 162 (Denosumab, Denosumab (AMG 162))

huCART19-IL18 (huCART19-IL18)

Adebrelimab Combined with Bevacizumab and Docetaxel (Adebrelimab Combined with Bevacizumab and Docetaxel)

mesna, cisplatin, etoposide, rituximab (mesna, cisplatin, etoposide, rituximab)

lintuzumab (lintuzumab)

pembrolizumab (Keytruda, BXCL701 plus Pembrolizumab)

HuC242-DM4 (HuC242-DM4)

B4T2-001 Autologous CAR T cells (B4T2-001 Autologous CAR T cells)

CAT19T2 (CD19 CAR T-Cell, CD19 CAR T-Cell(CAT19T2))

trastuzumab (Herceptin, Post-operative treatment trastuzumab mono therapy)

trastuzumab (Herceptin, Capecitabine,Trastuzumab, and Pertuzumab)